Cure My Disease

Don't miss your cure!

 Log in / Sign up

E-Cig flavor study targets smokers with opioid addiction

NCT ID NCT07594717

Recruiting now Knowledge-focused Sponsor: Prisma Health-Upstate Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how different e-cigarette flavors appeal to adults who have opioid use disorder and are on buprenorphine treatment. Participants will smell and rate 11 flavors for sweetness, coolness, strength, and how likely they'd use them again. The goal is to find flavors that might help these individuals switch from smoking to potentially less harmful e-cigarettes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
E-cigarette flavors (sweet-cooling, sweet non-cooling, tobacco)
What this could lead to
If successful, this study could identify e-cigarette flavors that make switching from smoking more appealing for people with opioid use disorder, potentially reducing harm from cigarettes.
What could go wrong
This is a small, early-stage observational study (70 participants) that only measures flavor preferences, not actual health outcomes. Results may not apply to all e-cigarette users or lead to any real-world changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NICOTINE USE DISODER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nicotine dependence opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NICOTINE USE DISODER OPIOID USE DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Prisma Health Recovery Clinic-Greenville

    RECRUITING

    Greenville, South Carolina, 29605, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.